Cluster Headaches are an uncommon, severe form of primary neurovascular headaches. It is the most painful form of headaches, with the pain occurring on one side of the head and behind or above the eye or at the temple, most commonly.
Cluster Headache patients have typical trigeminal-autonomic symptoms, such as ptosis, sweating, and miosis. In addition to trigeminal-autonomic symptoms, a large proportion of patients with Cluster Headaches have migraine-like features such as photophobia or osmophobia; thus, many patients are not correctly diagnosed and are misdiagnosed with a migraine disorder instead.
According to DelveInsight’s analysts, the total prevalent Cluster Headache population in the 7MM countries was estimated to be 877,859 cases in 2020. A higher percentage of the male population is affected by Cluster Headache as compared to the female population.
DelveInsight’s “Cluster Headache Market” report provides a thorough comprehension of the Cluster Headache, historical and forecasted epidemiology, and the Cluster Headache market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Cluster Headache market report also proffers an analysis of the current Cluster Headache treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
For further information on Market Impact by Therapies, visit: Global Cluster Headache Drug Treatment Market
Some of the key takeaways of the Cluster Headache Market Research Report
The Cluster Headache Market Report provides historical as well as forecasted epidemiological analysis segmented into:
Get a sample copy of this report: Cluster Headache Market Landscape
Cluster Headache Emerging Therapies Along with Key Players
To conclude, Cluster Headache Market Growth will upsurge due to the launch of emerging therapies that are better in efficacy and/or with a more favorable safety profile, development of a genetic approach, and a large cohort of patients. Since the entire landscape was till recently was devoid of any effective pharmaceutical treatment option, any significant development in this direction is expected to create a tectonic impact on the existing market scenario nevertheless, clinical trials challenges, economic burden, and lack of doctor’s knowledge regarding the disease will hinder Cluster Headache Market.
Request for a Webex demo of the report @ Cluster Headache Treatment Market Size
Scope of the Cluster Headache Market Insight Report
Table of Contents
1
Cluster Headache Key Insights
2
Cluster Headache Report Introduction
3
Cluster Headache Market Overview at a Glance
4
Executive Summary of Cluster Headache
5
Cluster Headache Disease Background and Overview
6
Cluster Headache Epidemiology and Patient Population
7
7MM Total Diagnosed Cluster Headache Prevalent Population
7.1
The United States
7.2
EU5 Countries
7.2.1
Germany
7.2.2
France
7.2.3
Italy
7.2.4
Spain
7.2.5
The United Kingdom
7.3
Japan
8
Cluster Headache Case Reports
9
Cluster Headache Marketed Products
9.1
EMGALITY (Galcanezumab-gnlm): Eli Lilly and Company
10
Cluster Headache Emerging Drugs
10.1
VYEPTI (Eptinezumab): Lundbeck Seattle BioPharmaceutical
10.2
Civamide (Zucapsaicin): Winston Laboratories
11
Other Cluster Headache Drugs under Development
11.1
Zolmitriptan transdermal (C213): Zosano Pharma
12
7MM Cluster Headache Market Analysis
12.1
The United States Cluster Headache Market Size
12.2
EU-5 Cluster Headache Market Size
12.2.1
Germany Market Size
12.2.2
France Market Size
12.2.3
Italy Market Size
12.2.4
Spain Market Size
12.2.5
The United Kingdom Market Size
12.3
Japan Cluster Headache Market Size
13
KOL Views
14
Cluster Headache Market Drivers
15
Cluster Headache Market Barriers
16
SWOT Analysis of Cluster Headache
17
Cluster Headache Unmet Needs
18
Cluster Headache Market Access
19
Appendix
20
DelveInsight Capabilities
21
Disclaimer
22
About DelveInsight
Browse full report with detailed TOC with charts, figures, tables @ Cluster Headache Treatment Market Report
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/cluster-headache-market